Basilea Pharmaceutica Ltd (BPMUF)
44.45
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Basilea Pharmaceutica 1 Year Total Returns (Daily): -14.52% for May 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 03, 2024 | -14.52% |
May 02, 2024 | -14.52% |
May 01, 2024 | -14.52% |
April 30, 2024 | -14.52% |
April 29, 2024 | -14.52% |
April 26, 2024 | -14.52% |
April 25, 2024 | -14.52% |
April 24, 2024 | -14.52% |
April 23, 2024 | -14.52% |
April 22, 2024 | -14.52% |
April 19, 2024 | -14.52% |
April 18, 2024 | -14.52% |
April 17, 2024 | -14.52% |
April 16, 2024 | -14.52% |
April 15, 2024 | -14.52% |
April 12, 2024 | -14.52% |
April 11, 2024 | -14.52% |
April 10, 2024 | -14.52% |
April 09, 2024 | -21.63% |
April 08, 2024 | -21.63% |
April 05, 2024 | -21.63% |
April 04, 2024 | -21.63% |
April 03, 2024 | -21.63% |
April 02, 2024 | -21.63% |
April 01, 2024 | -21.63% |
Date | Value |
---|---|
March 28, 2024 | -21.63% |
March 27, 2024 | -21.63% |
March 26, 2024 | -21.63% |
March 25, 2024 | -21.63% |
March 22, 2024 | -21.63% |
March 21, 2024 | -21.63% |
March 20, 2024 | -21.63% |
March 19, 2024 | -21.63% |
March 18, 2024 | -21.63% |
March 15, 2024 | -21.63% |
March 14, 2024 | -21.63% |
March 13, 2024 | -21.63% |
March 12, 2024 | -21.63% |
March 11, 2024 | -21.63% |
March 08, 2024 | -21.63% |
March 07, 2024 | -21.63% |
March 06, 2024 | -21.63% |
March 05, 2024 | -21.63% |
March 04, 2024 | -21.63% |
March 01, 2024 | -21.63% |
February 29, 2024 | -21.63% |
February 28, 2024 | -21.63% |
February 27, 2024 | -21.63% |
February 26, 2024 | -21.63% |
February 23, 2024 | -21.63% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-47.64%
Minimum
Jun 13 2019
51.92%
Maximum
Jul 08 2020
3.06%
Average
5.97%
Median
1 Year Total Returns (Daily) Benchmarks
AC Immune SA | 29.19% |
CRISPR Therapeutics AG | 13.62% |
Addex Therapeutics Ltd | -38.14% |
NLS Pharmaceutics Ltd | -89.70% |
Molecular Partners AG | -41.47% |